YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
6.34
-0.77 (-10.83%)
Mar 18, 2026, 4:00 PM EDT - Market closed
YD Bio Market Cap
YD Bio has a market cap or net worth of $445.83 million as of March 18, 2026. Its market cap has increased by 879.84% in one year.
Market Cap
445.83M
Enterprise Value
442.72M
1-Year Change
879.84%
Ranking
Category
Stock Price
$6.34
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $445.83M, an increase of 200.51%. That is a compound annual growth rate of 23.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 499.97M | -41.67% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DBV Technologies | 555.94M |
| ADC Therapeutics | 539.94M |
| Rocket Pharmaceuticals | 523.30M |
| Vanda Pharmaceuticals | 516.60M |
| Invivyd | 514.32M |
| CorMedix | 513.83M |
| Fulcrum Therapeutics | 513.49M |
| Upstream Bio | 509.04M |